Acute Psychosis as the Initial Presentation of MS: A Case Report

A Aggarwal1, Dd Sharma, R Kumar

  • 1Ashish Aggarwal Department of Psychiatry Indira Gandhi Medical College Shimla-171001 Himachal Pradesh India Tel: +91 0921 883 2616

International MS Journal
|June 22, 2011
PubMed

Insights

Psychiatric disorders can manifest in multiple sclerosis (MS) patients, sometimes mimicking acute psychosis. This case highlights the rare presentation of MS with stress-associated psychosis, necessitating broader differential diagnoses.

Area of Science:

  • Neuroimmunology
  • Psychiatry
  • Neurology

Background:

  • Multiple sclerosis (MS) is frequently linked with psychiatric disorders, either as a disease manifestation or treatment side effect.
  • Some MS patients present initially with psychiatric symptoms, including infrequently reported atypical psychosis.
  • Acute psychosis with stress-like features is a rare initial presentation in MS.

Observation:

  • This case report details an individual presenting with acute psychosis symptoms typically associated with stress.
  • The patient's presentation mimicked functional psychosis, prompting a need for careful differential diagnosis.
  • The underlying cause was identified as an acute onset of demyelinating disease.

Findings:

  • Acute demyelinating disease can present with the clinical phenotype of acute psychosis associated with stress.
  • This presentation is rare but underscores the importance of considering neurological conditions in psychiatric emergencies.
  • Early recognition is crucial for appropriate management and treatment.

Implications:

  • Clinicians should consider demyelinating diseases like MS in the differential diagnosis of acute psychosis, especially when stress-related features are present.
  • This case emphasizes the diverse neurological manifestations of MS and the importance of a comprehensive diagnostic approach.
  • Prompt diagnosis and treatment of MS can prevent long-term neurological damage and improve patient outcomes.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...